Abstract:Numerous studies have shown that many patients who suffer from type 2 diabetes mellitus exhibit cognitive dysfunction and neuronal synaptic impairments. Therefore, growing evidence suggests that type 2 diabetes mellitus has a close relationship with occurrence and progression of neurodegeneration and neural impairment in Alzheimer's disease. However, the relationship between metabolic disorders caused by type 2 diabetes mellitus and neurodegeneration and neural impairments in Alzheimer's disease is still not fully determined. Thus, in this study, we replicated a type 2 diabetic animal model by subcutaneous injection of newborn Sprague-Dawley rats with monosodium glutamate during the neonatal period. At 3 months old, the Barnes maze assay was performed to evaluate spatial memory function. Microelectrodes were used to measure electrophysiological function in the hippocampal CA1 region. Western blot assay was used to determine expression levels of glutamate ionotropic receptor NMDA type subunit 2A (GluN2A) and GluN2B in the hippocampus. Enzyme-linked immunosorbent assay was used to determine levels of interleukin-1β, tumor necrosis factor α, and interleukin-6 in the hippocampus and cerebral cortex, as well as hippocampal amyloid beta (Aβ)1-40 and Aβ1-42 levels. Our results showed that in the rat model of type 2 diabetes mellitus caused by monosodium glutamate exposure during the neonatal period, latency was prolonged and the number of errors increased in the Barnes maze. Further, latency was increased and time in the escape platform quadrant shortened. Number of times crossing the platform was also reduced in the Morris water maze. After high frequency stimulation of the hippocampus, synaptic transmission was inhibited, expression of GluN2A and GluN2B were decreased in the hippocampus, expression of interleukin 1β, interleukin 6, and tumor necrosis factor α was increased in the hippocampus and cortex, and levels of Aβ1-40 and Aβ1-42 were increased in the hippocampus. These findings confirm that type 2 diabetes mellitus induced by neonatal monosodium glutamate exposure results in Alzheimer-like neuropathological changes and further causes cognitive deficits and neurodegeneration in young adulthood.

Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET

Reduced SV2A and GABA A receptor levels in the brains of type 2 diabetic rats revealed by [ 18 F]SDM-8 and [ 18 F]flumazenil PET

[The Investigation of Syn and NPY Expression in Brain Tissues of Diabetic Model Rat Induced by Streptozotocin].

Specific Changes of Somatostatin Mrna Expression in the Frontal Cortex and Hippocampus of Diabetic Rats

Analysis of Neuron–astrocyte Metabolic Cooperation in the Brain of Db/db Mice with Cognitive Decline Using 13C NMR Spectroscopy

A Novel Thiazolidinediones ATZD2 Rescues Memory Deficits in a Rat Model of Type 2 Diabetes Through Antioxidant and Anti-Inflammation

Cognitive decline in type 2 diabetic db/db mice may be associated with brain region-specific metabolic disorders.

Cognitive Deficits and Alzheimer-like Neuropathological Impairments During Adolescence in a Rat Model of Type 2 Diabetes Mellitus

Cerebral Perfusion Alterations in Type 2 Diabetes and Its Relation to Insulin Resistance and Cognitive Dysfunction

Three-dimensional-arterial spin labeling perfusion correlation with diabetes-associated cognitive dysfunction and vascular endothelial growth factor in type 2 diabetes mellitus rat

The Research on the Relationship of RAGE, LRP-1, and Aβ Accumulation in the Hippocampus, Prefrontal Lobe, and Amygdala of STZ-Induced Diabetic Rats

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.

Establishment of Animal Model of Type 2 Diabetes and 18F-FP-(+)-DTBZ PET Imaging Study

Exploratory Dual PET imaging of [18F] fluorodeoxyglucose and [11C]acetoacetate in type 2 diabetic nonhuman primates

Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats

The fractional amplitude of low-frequency fluctuations signals related to amyloid uptake in high-risk populations—A pilot fMRI study

Exacerbation of Poststroke Dementia by Type 2 Diabetes is Associated with Synergistic Increases of Β-Secretase Activation and Β-Amyloid Generation in Rat Brains

Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus

Amyloid deposition and small vessel disease are associated with cognitive function in older adults with type 2 diabetes

Cognitive impairments in type 1 diabetes mellitus model mice are associated with synaptic protein disorders

Changes in hippocampal volume, synaptic plasticity and amylin sensitivity in an animal model of type 2 diabetes are associated with increased vulnerability to amyloid-beta in advancing age